Citigroup Inc. Sells 400,042 Shares of Avantor, Inc. $AVTR

Citigroup Inc. trimmed its position in shares of Avantor, Inc. (NYSE:AVTR) by 11.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,072,134 shares of the company’s stock after selling 400,042 shares during the period. Citigroup Inc. owned approximately 0.45% of Avantor worth $38,340,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Sector Gamma AS lifted its holdings in shares of Avantor by 28.0% during the third quarter. Sector Gamma AS now owns 477,104 shares of the company’s stock worth $5,954,000 after buying an additional 104,466 shares during the last quarter. Greenhaven Associates Inc. bought a new position in Avantor during the third quarter worth $228,528,000. Voss Capital LP acquired a new position in Avantor during the 2nd quarter valued at $6,057,000. ABS Direct Equity Fund LLC bought a new stake in Avantor in the 3rd quarter valued at $1,248,000. Finally, Tredje AP fonden boosted its holdings in Avantor by 110.7% in the 2nd quarter. Tredje AP fonden now owns 110,981 shares of the company’s stock valued at $1,494,000 after purchasing an additional 58,304 shares during the period. 95.08% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Avantor news, Director Gregory T. Lucier purchased 50,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 19th. The shares were acquired at an average cost of $9.16 per share, for a total transaction of $458,000.00. Following the transaction, the director directly owned 50,000 shares in the company, valued at approximately $458,000. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Director Gregory L. Summe purchased 100,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The shares were acquired at an average cost of $9.40 per share, with a total value of $940,000.00. Following the completion of the acquisition, the director directly owned 400,000 shares in the company, valued at approximately $3,760,000. This represents a 33.33% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have bought 500,000 shares of company stock valued at $5,279,500. 1.20% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

AVTR has been the subject of a number of research analyst reports. Barclays cut their price objective on shares of Avantor from $12.00 to $9.00 and set an “equal weight” rating for the company in a research report on Thursday, February 12th. Stifel Nicolaus set a $10.00 price target on Avantor in a report on Thursday, February 12th. Robert W. Baird set a $11.00 price objective on Avantor in a report on Thursday, February 12th. UBS Group restated a “neutral” rating and issued a $10.50 target price on shares of Avantor in a research note on Thursday, February 12th. Finally, TD Cowen reiterated a “hold” rating on shares of Avantor in a research note on Thursday, February 12th. Three analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Avantor currently has an average rating of “Hold” and a consensus price target of $11.83.

Avantor Price Performance

Shares of AVTR stock opened at $9.10 on Wednesday. The stock’s fifty day simple moving average is $11.10 and its 200 day simple moving average is $12.07. Avantor, Inc. has a one year low of $8.83 and a one year high of $18.02. The firm has a market cap of $6.21 billion, a price-to-earnings ratio of -11.67, a P/E/G ratio of 3.50 and a beta of 0.94. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.The company had revenue of $1.66 billion during the quarter, compared to analysts’ expectations of $1.64 billion. During the same period last year, the business earned $0.27 earnings per share. The business’s revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. On average, analysts expect that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.